Design of a Multi-Source Post-Marketing Study to Evaluate Pregnancy and Infant Outcomes in Women With Multiple Sclerosis Who Were Exposed to Ocrelizumab During, or Within 6 Months Before, Pregnancy (P4.372)Andrea V. Margulis, David Wormser, Sonia Hernández–Dı́az et al.|Neurology|2018Cited by 3